Relative survival following response to 7 + 3 versus azacytidine is similar in acute myeloid leukemia and high-risk myelodysplastic syndromes: an analysis of four SWOG studies

Relative survival following response to 7 + 3 versus azacytidine is similar in acute myeloid leukemia and high-risk myelodysplastic syndromes: an analysis of four SWOG studiesRelative survival following response to 7 + 3 versus azacytidine is similar in acute myeloid leukemia and high-risk myelodysplastic syndromes: an analysis of four SWOG studies, Published online: 12 October 2018; doi:10.1038/s41375-018-0275-xRelative survival following response to 7 + 3 versus azacytidine is similar in acute myeloid leukemia and high-risk myelodysplastic syndromes: an analysis of four SWOG studies

Source: Leukemia - October 12, 2018 Category: Hematology Authors: Megan Othus Mikkael A. Sekeres Sucha Nand Guillermo Garcia-Manero Frederick R. Appelbaum Harry P. Erba Eli Estey Source Type: research